Jim Post is currently the CEO of ALCOR Scientific and serves on the Board of Directors at Dreampath Diagnostics. With over 20 years of experience in the healthcare and medical device industry, they have successfully led significant initiatives, including a $1.14 billion divestiture at Thermo Fisher Scientific. Known for their strong negotiation skills and commitment to improving operational efficiency, Jim has directed multiple business units and fostered impactful partnerships throughout their career. They hold a Bachelor of Arts in Psychology/Sociology and a certification in Business Management from the University of Rochester.
This person is not in the org chart
This person is not in any teams
This person is not in any offices